Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Targeted Metabolomics Identifies the Cytochrome P450 Monooxygenase Eicosanoid Pathway as a Novel Therapeutic Target of Colon Tumorigenesis.

Wang W, Yang J, Edin ML, Wang Y, Luo Y, Wan D, Yang H, Song CQ, Xue W, Sanidad KZ, Song M, Bisbee HA, Bradbury JA, Nan G, Zhang J, Shih PB, Lee KSS, Minter LM, Kim D, Xiao H, Liu JY, Hammock BD, Zeldin DC, Zhang G.

Cancer Res. 2019 Apr 15;79(8):1822-1830. doi: 10.1158/0008-5472.CAN-18-3221. Epub 2019 Feb 25.

PMID:
30803995
2.

Fasting and postprandial soluble epoxide hydrolase-associated eicosanoids of remitted patients with eating disorder.

Yang J, Shih PB.

Data Brief. 2018 Jan 31;17:334-338. doi: 10.1016/j.dib.2018.01.028. eCollection 2018 Apr.

3.

Spectral efficient 64-QAM-OFDM terahertz communication link.

Hermelo MF, Shih PB, Steeg M, Ng'oma A, Stöhr A.

Opt Express. 2017 Aug 7;25(16):19360-19370. doi: 10.1364/OE.25.019360.

PMID:
29041130
4.

Personalized polyunsaturated fatty acids as a potential adjunctive treatment for anorexia nervosa.

Shih PB, Morisseau C, Le T, Woodside B, German JB.

Prostaglandins Other Lipid Mediat. 2017 Nov;133:11-19. doi: 10.1016/j.prostaglandins.2017.08.010. Epub 2017 Sep 2. Review.

5.

Modified Mediterranean Diet for Enrichment of Short Chain Fatty Acids: Potential Adjunctive Therapeutic to Target Immune and Metabolic Dysfunction in Schizophrenia?

Joseph J, Depp C, Shih PB, Cadenhead KS, Schmid-Schönbein G.

Front Neurosci. 2017 Mar 27;11:155. doi: 10.3389/fnins.2017.00155. eCollection 2017.

6.

Integrating multi-omics biomarkers and postprandial metabolism to develop personalized treatment for anorexia nervosa.

Shih PB.

Prostaglandins Other Lipid Mediat. 2017 Sep;132:69-76. doi: 10.1016/j.prostaglandins.2017.02.002. Epub 2017 Feb 21.

7.

Dysregulation of soluble epoxide hydrolase and lipidomic profiles in anorexia nervosa.

Shih PB, Yang J, Morisseau C, German JB, Zeeland AA, Armando AM, Quehenberger O, Bergen AW, Magistretti P, Berrettini W, Halmi KA, Schork N, Hammock BD, Kaye W.

Mol Psychiatry. 2016 Apr;21(4):537-46. doi: 10.1038/mp.2015.26. Epub 2015 Mar 31.

8.

Evidence for the role of EPHX2 gene variants in anorexia nervosa.

Scott-Van Zeeland AA, Bloss CS, Tewhey R, Bansal V, Torkamani A, Libiger O, Duvvuri V, Wineinger N, Galvez L, Darst BF, Smith EN, Carson A, Pham P, Phillips T, Villarasa N, Tisch R, Zhang G, Levy S, Murray S, Chen W, Srinivasan S, Berenson G, Brandt H, Crawford S, Crow S, Fichter MM, Halmi KA, Johnson C, Kaplan AS, La Via M, Mitchell JE, Strober M, Rotondo A, Treasure J, Woodside DB, Bulik CM, Keel P, Klump KL, Lilenfeld L, Plotnicov K, Topol EJ, Shih PB, Magistretti P, Bergen AW, Berrettini W, Kaye W, Schork NJ.

Mol Psychiatry. 2014 Jun;19(6):724-32. doi: 10.1038/mp.2013.91. Epub 2013 Sep 3.

9.

Peptide YY (PYY) Gene Polymorphisms in the 3'-Untranslated Region and Proximal Promoter Regions Regulate Cellular Gene Expression and PYY Secretion and Metabolic Syndrome Traits in Vivo.

Shih PB, Wang L, Chiron S, Wen G, Nievergelt C, Mahata M, Khandrika S, Rao F, Fung MM, Mahata SK, Hamilton BA, O'Connor DT.

Endocr Rev. 2009 Dec 1;30(7):934. doi: 10.1210/edrv.30.7.9982. No abstract available.

PMID:
28199513
10.

Genetic variation in C-reactive protein (CRP) gene may be associated with risk of systemic lupus erythematosus and CRP concentrations.

Shih PB, Manzi S, Shaw P, Kenney M, Kao AH, Bontempo F, Barmada MM, Kammerer C, Kamboh MI.

J Rheumatol. 2008 Nov;35(11):2171-8. Epub 2008 Sep 15.

Supplemental Content

Support Center